New Publication Elaborates on TB4’s Effects on Dry Eye Syndrome and Other Potential Ophthalmic Disorders

ROCKVILLE, Md., Aug. 12, 2015 /PRNewswire RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) (“the Company” or “RegeneRx”), a clinical-stage drug development company focused on tissue protection, repair and regeneration, today announced a new peer-reviewed publication describing Thymosin beta 4’s (TB4) effects on dry eye syndrome and its potential value for the treatment of other ophthalmic disorders. The authors of the paper explained …

Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis

More than half of patients with multiple sclerosis have progressive disease characterised by accumulating disability. The absence of treatments for progressive multiple sclerosis represents a major unmet clinical need. On the basis of evidence that mesenchymal stem cells have a beneficial effect in acute and chronic animal models of multiple sclerosis, we aimed to assess the safety and efficacy of …

Zinc Deficiency Linked to Immune System Response, Specifically Inflammation

Zinc has a long history known as the mineral of the immune system. New research from Oregon State University demonstrated that it appears to affect how the immune system responds to inflammation. A zinc deficiency may play a role in chronic diseases that involve inflammation, such as cardiovascular disease, cancer and diabetes. I see this deficiency frequently on plasma zinc …

People with MS may have lower levels of certain nutrients

According to a newly released study that will be presented at the American Academy of Neurology’s 67th Annual Meeting in Washington, DC this April, women with multiple sclerosis (MS) may have lower levels of important antioxidant and anti-inflammatory nutrients, such as folate and vitamin E, than healthy people. This study was supported by the National Institute of Neurological Disorders and …